* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Slide 1
Survey
Document related concepts
Polysubstance dependence wikipedia , lookup
Orphan drug wikipedia , lookup
Compounding wikipedia , lookup
Pharmacognosy wikipedia , lookup
List of off-label promotion pharmaceutical settlements wikipedia , lookup
Theralizumab wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Neuropharmacology wikipedia , lookup
Prescription drug prices in the United States wikipedia , lookup
Drug interaction wikipedia , lookup
Prescription costs wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Transcript
Who we are – DPAc represents a new approach to early drug discovery. The concept is simple but powerful: bring together the insight and creativity of the academic world with the drug discovery expertise of GlaxoSmithKline (GSK). We are a dedicated team of experienced drug discovery scientists – internal champions for your project and a gateway to the global resources of GSK. Our goal is to establish truly integrated partnerships that can translate innovative research into medicines that benefit patients. Who you are – An academic partner with the unique know-how and key expertise that is essential for the successful progression of a drug target. You are a researcher who wants to see their innovative ideas turned into a medicine. What are we looking for? 1. A coherent therapeutic hypothesis based on sound understanding of patho-mechanism in any disease area. 2. A defined drug target with understanding of the pharmacology (e.g. antagonist, agonist) and link to the disease. 3. Bioassays that can be adapted to the high throughput screening modes necessary to support drug discovery. 4. We are not able to consider drug re-purposing efforts, biomarker strategies or novel discovery platforms. What do we offer? 1. If selected, funding to support collaborative discovery research including additional target validation and high throughput screening at GSK facilities. Link to DPAc Website http://www.dpac.gsk.com/ Link to case studies http://www.openinnovation.gsk.com/proven.php Proposals should be submitted to: Peter Kotsonis ([email protected]) in the Office of Innovation, Technology & Alliances by July 25th, 2016